IRB COVID-19 Guidance - March 31, 2020

March 31, 2020 @ 9:03 a.m.

Font Size

IRB COVID-19 Guidance
March 31, 2020

Investigators conducting human subjects research must consider the risk(s) to participants within the current COVID-19 environment.  Risk of exposure to COVID-19 resulting from participation in human research may arise when research procedures include face-to-face interactions with participants, physical presence of participants on Auburn University campus or research site, or other scenarios.  Investigators are encouraged, as appropriate to meet research objectives, to consider replacing in-person activities with remote activities, technology-assisted participant interactions, or other methods to reduce the risk of participant exposure to COVID-19.

Investigators with active IRB protocols and those that are submitting new applications to the IRB may need to submit modifications to approved protocols and/or provide additional information related to the current COVID-19 environment. 

Investigators should monitor the Human Subjects What’s New webpage for updates.


Categories: OVPRED

Related Stories

Office of Innovation Advancement and Commercialization ready to assist AU innovators with IP, commercialization, startups

COVID-19 Salary Guidance for Grants/Contracts - March 20, 2020

A message from the VPRED: COVID-19 and Research Continuity Guidance